| ๐ Image | |
| Clinical data | |
|---|---|
| Other names |
|
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.000.629 ๐ Edit this at Wikidata |
| Chemical and physical data | |
| Formula | C12H13N3O2 |
| Molar mass | 231.255 gยทmolโ1 |
| 3D model (JSmol) | |
| |
| ๐ โ N๐ check Y (what is this?) (verify) | |
Triaziquone is a drug used in chemotherapy.
It is aziridinylbenzoquinone-based, and may have potential antineoplastic activity. [1]
It is an alkylating agent. It can react with DNA to form intrastrand crosslinks. It is a member of aziridines as well. [2]
References
[edit]- ^ PubChem. "Triaziquone". pubchem.ncbi.nlm.nih.gov. Retrieved 2023-10-10.
- ^ Huang CH, Kuo HS, Liu JW, Lin YL (June 2009). "Synthesis and antitumor evaluation of novel bis-triaziquone derivatives". Molecules (Basel, Switzerland). 14 (7): 2306โ16. doi:10.3390/molecules14072306. PMC 6255275. PMID 19633605.
Hidden categories:
- Articles with short description
- Short description matches Wikidata
- Short description is different from Wikidata
- Articles with changed ChemSpider identifier
- Articles with changed EBI identifier
- ECHA InfoCard ID from Wikidata
- Articles with changed InChI identifier
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- All stub articles
